The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension.

[1]  L. Kuller,et al.  SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.

[2]  G. Berglund,et al.  The Multifactor Primary Prevention Trial in Göteborg, Sweden. Comparison with a previously untreated population sample. , 1986, Drugs.

[3]  S. MacMahon,et al.  Antihypertensive treatment and plasma lipoprotein levels. The associations in data from a population study. , 1986, The American journal of medicine.

[4]  J. Neaton,et al.  Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial. , 1986, The American journal of medicine.

[5]  D. Hunninghake,et al.  Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension. , 1986, The American journal of medicine.

[6]  K. Anderson,et al.  A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the framingham study , 1986 .

[7]  J. Stamler,et al.  Need to prevent and control high-normal and high blood pressure, particularly so-called "mild" hypertension: epidemiological and clinical data. , 1985, Preventive medicine.

[8]  C. Bulpitt,et al.  Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial , 1985, The Lancet.

[9]  L. Kuller,et al.  Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. , 1984, American heart journal.

[10]  J. Cutler,et al.  Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. , 1984, The American journal of medicine.

[11]  P. Leren.  Effect of alpha- and beta-blocker therapy on blood lipids: European experience. , 1984, The American journal of medicine.

[12]  R. Ames,et al.  Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: lipid alterations and glucose intolerance. , 1983, American heart journal.

[13]  P. Weidmann,et al.  Effects of antihypertensive therapy on serum lipoproteins. , 1983, Hypertension.

[14]  B. Hansson,et al.  Beta-blockers and lipid metabolism. , 1977, British medical journal.

[15]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[16]  J deOliveira,et al.  Lipid metabolism and atherosclerosis , 1963 .

[17]  J. Schroeder.  SARCOMA (?) OF THIGH, WITH SECONDARY SARCOMA (?) OF INGUINAL REGION, LIVER AND LUNGS: RECOVERY AFTER INTENSIVE DEEP ROENTGEN IRRADIATION , 1923 .